Stockreport

Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors

Xilio Therapeutics, Inc.  (XLO) 
PDF WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked imm [Read more]